Contact this trialFirst, we need to learn more about you.
ABX-002 for Bipolar Depression
Recruiting1 awardPhase 2
Staten Island, New York
This trial aims to see if adding ABX-002 to participants' current treatment can affect brain chemistry related to anti-depressive effects. The trial includes 30 adults with bipolar disorder and 5 healthy
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service